Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.450
0.00 (0.00%)
Jan 16, 2026, 4:00 PM EST
HRGN Market Cap
HRGN has a market cap or net worth of $25.49 million as of January 20, 2026. Its market cap has decreased by -31.51% in one year.
Market Cap
25.49M
Enterprise Value
24.40M
Revenue
743.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.45
Market Cap Chart
Since October 21, 2013, HRGN's market cap has decreased from 48.00M to 25.49M, a decrease of -46.89%. That is a compound annual growth rate of -5.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 25.49M | -19.31% |
| Dec 31, 2025 | 31.59M | -33.41% |
| Dec 30, 2024 | 47.44M | -31.84% |
| Dec 29, 2023 | 69.60M | 3.94% |
| Dec 30, 2022 | 66.96M | 170.54% |
| Dec 31, 2021 | 24.75M | 110.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |